| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 61 | 31 | 827 | 8,172 | | Cost of Revenue | 178 | 26 | 731 | 6,160 | | | Gross Profit | (117) | 5 | 95 | 2,012 | | | Operating Expenses | | Research Development | 1,248 | 1,015 | 1,002 | 1,278 | | Selling General and Administrative | 1,240 | 1,312 | 1,296 | 858 | | Non Recurring | (9) | 9 | (0) | 118 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,606) | (2,332) | (2,202) | (242) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8) | 4 | 22 | (2,782) | | Earnings Before Interest And Taxes | (2,614) | (2,327) | (2,180) | (3,024) | | Interest Expense | 3,387 | 3,031 | 1,864 | 1,342 | | Income Before Tax | (6,001) | (5,358) | (4,044) | (4,366) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,001) | (5,358) | (4,044) | (4,366) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,992) | (5,358) | (4,044) | (4,366) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,992) | ($5,358) | ($4,044) | ($4,366) |
|
0.31% Nasdaq 
0.05%
Income Statement
